Scandinavian ChemoTech (Sweden) Today
| CMOTEC-B | SEK 1.74 0.04 2.35% |
Performance0 of 100
| Odds Of DistressOver 64
|
Scandinavian ChemoTech is trading at 1.74 as of the 30th of November 2024, a 2.35 percent increase since the beginning of the trading day. The stock's open price was 1.7. Scandinavian ChemoTech has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Scandinavian ChemoTech AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden. The company has 10.64 M outstanding shares. More on Scandinavian ChemoTech AB
Moving together with Scandinavian Stock
Moving against Scandinavian Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Scandinavian Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Scandinavian ChemoTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Scandinavian ChemoTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
Scandinavian ChemoTech AB (CMOTEC-B) is traded on Stockholm Exchange in Sweden and employs 6 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 113.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Scandinavian ChemoTech's market, we take the total number of its shares issued and multiply it by Scandinavian ChemoTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Scandinavian ChemoTech operates under Healthcare sector and is part of Biotechnology industry. The entity has 10.64 M outstanding shares.
Scandinavian ChemoTech AB has accumulated about 5.62 M in cash with (19.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65.
Check Scandinavian ChemoTech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Scandinavian ChemoTech is kr113.35 Million. Scandinavian ChemoTech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Scandinavian Ownership Details
Scandinavian ChemoTech Risk Profiles
Although Scandinavian ChemoTech's alpha and beta are two of the key measurements used to evaluate Scandinavian ChemoTech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.84 | |||
| Standard Deviation | 3.95 | |||
| Variance | 15.58 | |||
| Risk Adjusted Performance | (0.01) |
Scandinavian Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Scandinavian ChemoTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Scandinavian ChemoTech Corporate Management
Elected by the shareholders, the Scandinavian ChemoTech's board of directors comprises two types of representatives: Scandinavian ChemoTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scandinavian. The board's role is to monitor Scandinavian ChemoTech's management team and ensure that shareholders' interests are well served. Scandinavian ChemoTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scandinavian ChemoTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefan Frick | CEO Founder | Profile | |
| Jonathan Furelid | Head relation | Profile | |
| Prabhat Rastogi | Chief India | Profile | |
| Ann Ohlsson | Head Fin | Profile | |
| Suhail Mufti | Local Director | Profile |
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.